Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06219538Not ApplicableCompleted

DAISY Uterine Drain Device Evaluation

Role: lead

NCT07296419Not ApplicableRecruiting

Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems

Role: lead

NCT04876846Not ApplicableCompleted

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Role: lead

NCT06405984Early Phase 1Completed

Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE

Role: lead

NCT05147584Not ApplicableTerminated

Trans-abdominal Fetal Pulse Oximetry

Role: lead

NCT04081584Terminated

Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering

Role: lead

NCT04081623Terminated

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

Role: lead

All 7 trials loaded